We report a case of orbitofrontal fibrous dysplasia that presented with three episodes of acute recurrent visual loss. All the episodes of vision loss were reversed by corticosteroid treatment. Though surgical intervention is generally advocated when fibrous dysplasia is associated with visual loss, corticosteroid therapy may be tried when waiting for surgery or in patients contraindicated for surgery. This is second case reported in literature for successful treatment of fibrous dysplasia associated visual loss with steroid. Introduction Fibrous dysplasia (FD) is a progressive bone disease in which abnormal fibroblast proliferation results in the replacement of normal cancellous bone with an immature fibrous tissue that is poorly mineralized. Orbitofrontal fibrous dysplasia may develop within bone adjacent to the optic canal, grow gradually, and compress the optic nerve leading to visual disturbances (1,2,3). We report a case of a patient with unilateral optic neuropathy from fibrous dysplasia that suffered three acute recurrent visual losses which was responsive to steroid therapy. In our knowledge this is second case reported in the literature for successful treatment of fibrous dysplasia with steroid. Case report This 21 years old lady presented with history of painful visual loss of left eye to fingers counting from 1 meter one year back. She was seen by an Ophthalmologist and treated with intravenous (IV) Methylprednisolone for 5 days and regain her vision to 100% (6/6) on fourth day of treatment. Again after 3 months she developed visual blurring with visual acuity of 6/60 in left eye that was improved to 6/9 with oral steroid for 2 months. She presented to us with complain of progressive blurring of vision of left eye since 7 days. But she denied any symptoms such as proptosis, pain in the eyes and diplopia. In addition, she had no history of skin lesions, precocious puberty or other endocrine abnormalities. The patient had no other significant past medical history. General physical and systemic examinations were all normal. She can count only fingers from I meter distance. There was an afferent pupillary defect in the left eye. Slit-lamp examination was unremarkable. Funduscopy showed a normal optic disc. Goldmann visual field testing showed a cecocentral scotoma in the left eye and retrobulbar neuritis was diagnosed. Her blood routine and biochemical examination was normal. Her x-ray chest, routine urine examination, antinuclear antibody titre, anti-double stranded deoxyribonucleic acid titre and thyroid function test were normal. Visual evoked potentials (VEP) using pattern reversal showed significant delay in the P 100-wave latency on the left side. The latency of the right side was normal. Her cerebrospinal fluid routine examination was normal. In view of clinical history and examination supported by VEP and field examination, the patient was diagnosed as case of optic neuritis and started IV Methylprednisolone 1 gm / day for 5 days. After 4 days of treatment, her visual acuity had improved to 12/6 with resolution of the afferent pupillary defect and visual field improvement. Magnetic resonance imaging done at day five of IV Methylprednisolone revealed a diffuse thickening with mixed signal changes of the fronto-parieto-temporal bone and the greater wing of the sphenoid bone on the left side with compression of the left optic nerve (fig 1). The patient underwent orbito-cranial reconstruction and unilateral optic canal release using an extradural approach through a left fronto-temporal craniectomy. Histological findings confirmed the lesion to be typical fibrous dysplasia by presence of multiple small and irregular spicules of abundant immature bone without any osteoblastic lining separated by moderately cellular collagen tissue without any cellular atypia (fig 2). She recovered completely one month after the operation. Patient was stable over 1 year of follow-up. Postoperative follow-up did not reveal disturbances
展开▼